Celldex Therapeutics, Inc. (CLDX)

Celldex Therapeutics Market Cap

Celldex Therapeutics has a market cap or net worth of $2.06 billion as of March 24, 2026. Its market cap has increased by 45.36% in one year.

• Market Cap: 2.06B
• Enterprise Value: 1.60B
• 1-Year Change: 45.36%
• Ranking: #1942
• Category: Mid-Cap
• Stock Price: $30.92

Market Cap Chart

Since July 23, 2003, Celldex Therapeutics's market cap has increased from $148.10M to $2.06B, an increase of 1,289.76%. That is a compound annual growth rate of 12.31%.

Market Cap History

Date	Market Cap	% Change
Mar 20, 2026	2.06B	13.97%
Dec 31, 2025	1.80B	7.65%
Dec 31, 2024	1.68B	-10.56%
Dec 29, 2023	1.87B	-10.70%
Dec 30, 2022	2.10B	16.42%
Dec 31, 2021	1.80B	160.11%
Dec 31, 2020	693.20M	1,825.56%
Dec 31, 2019	36.00M	5.57%
Dec 31, 2018	34.10M	-91.17%
Dec 29, 2017	386.20M	7.76%
Dec 30, 2016	358.40M	-76.83%
Dec 31, 2015	1.55B	-5.39%
Dec 31, 2014	1.64B	-16.73%
Dec 31, 2013	1.96B	372.13%
Dec 31, 2012	415.90M	262.28%
Dec 30, 2011	114.80M	-13.10%
Dec 31, 2010	132.10M	-10.50%
Dec 31, 2009	147.60M	17.99%
Dec 31, 2008	125.10M	237.20%
Dec 31, 2007	37.10M	-62.68%
Dec 29, 2006	99.40M	-28.69%
Dec 30, 2005	139.40M	-6.44%
Dec 31, 2004	149.00M	-15.96%
Dec 31, 2003	177.30M	19.72%
Jul 23, 2003	148.10M	-

View and export this data all the way back to 2003. Sign Up Today.

Related Stocks

Company	Market Cap
Apellis Pharmaceuticals	2.20B
Veradermics	2.20B
Syndax Pharmaceuticals	2.14B
Galapagos NV	2.11B
Adaptive Biotechnologies	2.09B
Nektar Therapeutics	2.07B
Zai Lab	2.00B
Tyra Biosciences	2.00B